Cellebrite DI Ltd.CLBTNASDAQ
Loading
R&D Expense Growth TrendStable
Percentile Rank33
3Y CAGR-11.9%
5Y CAGR-1.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-11.9%/yr
Annual compound
5Y CAGR
-1.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value |
|---|---|
| 2025 | 15.71% |
| 2024 | 16.62% |
| 2023 | 4.67% |
| 2022 | 23.01% |
| 2021 | 20.53% |
| 2020 | 16.76% |
| 2019 | 0.00% |